171 related articles for article (PubMed ID: 3486562)
1. Residual masses after successful chemotherapy for testicular carcinoma.
Glowalla M
AJR Am J Roentgenol; 1986 Jun; 146(6):1184-6. PubMed ID: 3486562
[No Abstract] [Full Text] [Related]
2. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors of the testis.
Jacqmin D
Eur Urol; 2008 Feb; 53(2):272-3. PubMed ID: 18045771
[No Abstract] [Full Text] [Related]
3. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer tumors of the testis.
Culine S
Eur Urol; 2008 Feb; 53(2):273-4. PubMed ID: 18045772
[No Abstract] [Full Text] [Related]
4. Primary vs. post-chemotherapy retroperitoneal lymph node dissection (RPLND) in patients with presence of teratoma at orchiectomy.
Williams SB; Kacker R; Steele GS; Richie JP
Urol Oncol; 2012; 30(1):60-3. PubMed ID: 20189842
[TBL] [Abstract][Full Text] [Related]
5. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
[TBL] [Abstract][Full Text] [Related]
6. Retroperitoneal lymph node dissection (RPLND) post chemotherapy for non-seminomatous testicular neoplasms: what is the significance of residual masses at scanner control after chemotherapy and should they be removed?
Solé-Balcells F; Villavicencio H; Germá R
Prog Clin Biol Res; 1989; 303():759-62. PubMed ID: 2780671
[No Abstract] [Full Text] [Related]
7. [Aortic replacement during post chemotherapy retroperitoneal residual tumor resection for nonseminomatous germ cell tumor: a case report].
Matsuzaki M; Nakano M; Komatsu H; Ohashi K
Hinyokika Kiyo; 2005 Dec; 51(12):831-4. PubMed ID: 16440734
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
9. [Nerve-sparing retroperitoneal lymph node dissection for stage IIA testicular embryonal carcinoma: a case report].
Terachi T; Arai Y; Maeda S; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1992 Oct; 38(10):1191-4. PubMed ID: 1481782
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
van der Gaast A; Hoekstra JW; Croles JJ; Splinter TA
J Urol; 1991 Apr; 145(4):829-31. PubMed ID: 1706441
[TBL] [Abstract][Full Text] [Related]
11. [Significance pf retroperitoneal lymphadenectomy in the treatment of disseminated germinogenic testicular tumors after induction chemotherapy].
Mitin AV; Figurin KM; Matveev BP; Tiuliandin SA; Bukharin BV; Volkova MI; Matveev VB
Urologiia; 2000; (6):12-6. PubMed ID: 11186312
[No Abstract] [Full Text] [Related]
12. Management of the post chemotherapy subcentimeter residual mass: the case for observation.
Beck SD; Foster RS
World J Urol; 2009 Aug; 27(4):485-8. PubMed ID: 19603172
[No Abstract] [Full Text] [Related]
13. Benign intracranial hypertension during chemotherapy for testicular teratoma.
Marsh LF; Morgan DA; Jefferson D
Br J Radiol; 1988 Aug; 61(728):692. PubMed ID: 2458158
[No Abstract] [Full Text] [Related]
14. Chemotherapy of advanced testicular cancer.
Williams SD; Loehrer PJ; Einhorn LH
Semin Urol; 1984 Nov; 2(4):230-7. PubMed ID: 6209762
[No Abstract] [Full Text] [Related]
15. Primary carcinoid tumor of the testis with teratoma metastatic to the para-aortic lymph node.
Fujita K; Wada R; Sakurai T; Sashide K; Fujime M
Int J Urol; 2005 Mar; 12(3):328-31. PubMed ID: 15828968
[TBL] [Abstract][Full Text] [Related]
16. Salvage combination chemotherapy with docetaxel, ifosfamide and cisplatin (DIP): successful treatment of a case with metastatic testicular immature teratoma.
Kume H; Kakutani S; Tomita K; Kitamura T
Jpn J Clin Oncol; 2008 Feb; 38(2):143-5. PubMed ID: 18250203
[TBL] [Abstract][Full Text] [Related]
17. Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors.
Gelderman WA; Koops HS; Sleijfer DT; Oosterhuis JW; Oldhoff J
Cancer; 1986 Oct; 58(7):1418-21. PubMed ID: 2427186
[TBL] [Abstract][Full Text] [Related]
18. Transient tumor marker elevation following chemotherapy for germ cell tumors of the testis.
Horwich A; Peckham MJ
Cancer Treat Rep; 1986 Nov; 70(11):1329-31. PubMed ID: 2429765
[TBL] [Abstract][Full Text] [Related]
19. Vena cava resection during post chemotherapy lymphadenectomy for testis tumor.
Pantuck AJ; Barone JG; Cummings KB
Am Surg; 1995 May; 61(5):424-6. PubMed ID: 7733548
[TBL] [Abstract][Full Text] [Related]
20. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis.
Heidenreich A; Thüer D; Polyakov S
Eur Urol; 2008 Feb; 53(2):260-72. PubMed ID: 18045770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
